Ceftriaxone treatment of syphilis | Zendy

Georgiy L. Katunin | Zendy; Xenia I. Plakhova | Zendy; Nazirbek K. Abuduev | Zendy; Michael M. Vasiliev | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Ceftriaxone treatment of syphilis

Author(s) -

Georgiy L. Katunin,

Xenia I. Plakhova,

Nazirbek K. Abuduev,

Michael M. Vasiliev

Publication year - 2021

Publication title -

vestnik dermatologii i venerologii

Language(s) - English

Resource type - Journals

eISSN - 2313-6294

pISSN - 0042-4609

DOI - 10.25208/vdv1208

Subject(s) - ceftriaxone , syphilis , medicine , medline , intensive care medicine , antibiotics , family medicine , human immunodeficiency virus (hiv) , political science , law , microbiology and biotechnology , biology

The article presents literature data on the use of antibacterial drugs for the treatment of patients with syphilis, where the main focus is on ceftriaxone. Based on the materials of national and foreign studies, data on the effectiveness of ceftriaxone in the treatment of patients with various forms of syphilis have been analyzed, and information characterizing the pharmacological and pharmacokinetic features of ceftriaxone has been presented. Based on the scientific and clinical experience accumulated over previous years, both in Russia and abroad, some results of the use of ceftriaxone in the treatment of syphilis have been summed up. To search for the necessary literature, the PubMed, MedLine, Web of Science and RSCI databases were used.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research